What Are SNPs? The Tiny DNA Variants That Shape Your Health

TL;DR: SNPs (single nucleotide polymorphisms, pronounced "snips") are single-letter changes in your DNA sequence that account for most genetic variation between people. Each person carries roughly 5 million SNPs compared to the reference genome, and while most have no effect, some influence disease risk, drug response, and physical traits. SNP analysis is the foundation of modern genetic testing and personalized medicine.

Disclaimer: This article is for educational purposes. It does not constitute medical advice. Consult a healthcare professional for personalized guidance.

Your genome is 99.9% identical to every other person on Earth. That remaining 0.1% — roughly 3 to 5 million single-letter differences scattered across your 6.4 billion DNA base pairs — accounts for much of what makes you genetically unique. The vast majority of these differences are SNPs: single nucleotide polymorphisms. They influence everything from your eye color and caffeine metabolism to your risk of type 2 diabetes and your response to prescription medications. Understanding what SNPs are and how they work is the first step toward making sense of your own DNA analysis results.

What Is a Single Nucleotide Polymorphism?

A SNP (pronounced "snip") is a variation at a single position in the DNA sequence where one nucleotide — an A, T, C, or G — differs between individuals or between a person's two copies of a chromosome. If one person's DNA reads ...AAGCCTA... at a particular position and another person's reads ...AAGCTTA..., that C-to-T swap is a SNP.

SNP (single nucleotide polymorphism): A DNA sequence variation occurring at a single nucleotide position in the genome, present in at least 1% of the population, and representing the most common form of human genetic variation.

SNPs occur roughly once every 1,000 base pairs across the human genome. A typical individual carries approximately 5 million SNPs compared to the reference human genome, according to the National Human Genome Research Institute. To put this in perspective, NCBI's dbSNP database — the world's largest catalog of known human genetic variation — contained 1.2 billion unique reference SNP identifiers as of Build 157, released in March 2025.

Not all SNPs carry the same weight. Scientists classify them by location and functional impact:

• Nonsynonymous SNPs fall within protein-coding regions and change the amino acid sequence of a protein. These are the most likely to have a direct biological effect.
• Synonymous SNPs also sit in coding regions but do not change the amino acid due to the redundancy of the genetic code. They were once dismissed as silent, but some affect mRNA stability and translation speed.
• Noncoding SNPs reside in regulatory regions (promoters, enhancers, introns) and can alter when, where, and how much of a gene is expressed — often with significant health consequences.

Think of your genome as a 6.4-billion-letter instruction manual. SNPs are single-letter typos scattered throughout. Most are harmless — they fall in sections that don't change the meaning. But occasionally, a single-letter change in a critical instruction can alter how a protein is built or how much of it your cells produce.

How Do SNPs Affect Your Health?

SNPs in Protein-Coding Regions

The most dramatic example of a single SNP causing disease is rs334 in the HBB (beta-globin) gene. A single adenine-to-thymine change at codon 6 replaces the amino acid glutamic acid with valine, producing abnormal hemoglobin S. Two copies of this variant cause sickle cell disease. But carrying just one copy — the heterozygous state — confers an estimated 86% reduction in severe malaria risk, which explains why the variant remains common in populations historically exposed to malaria.

This illustrates a key principle: a SNP's impact depends on context. The same variant that causes a serious blood disorder in one genetic combination provides a survival advantage in another.

SNPs in Regulatory Regions

Many clinically significant SNPs never change a protein's amino acid sequence. Instead, they alter how genes are regulated. The well-studied MTHFR variant rs1801133 (commonly called C677T) reduces the activity of the MTHFR enzyme by approximately 70% in people with two copies of the T allele. This leads to elevated homocysteine levels, which has been linked to cardiovascular risk and complications during pregnancy. The variant is common — roughly 10-15% of people of European descent are homozygous TT carriers. If you want to understand this variant in depth, see our MTHFR gene explainer.

SNPs and Complex Disease Risk

Most common diseases — heart disease, type 2 diabetes, depression, many cancers — are not caused by a single SNP. Instead, they result from the combined effects of hundreds or thousands of genetic variants, each contributing a small increment of risk, interacting with environmental factors like diet, exercise, and stress.

Genome-wide association studies (GWAS) identify these disease-associated SNPs by comparing the genomes of thousands of affected individuals to unaffected controls. One of the strongest common-variant associations for type 2 diabetes is rs7903146 in the TCF7L2 gene: carriers of the risk allele face approximately twice the odds of developing the condition compared to non-carriers. Yet this single variant explains only a fraction of overall diabetes risk — a reminder that complex diseases live up to their name.

Genome-wide association study (GWAS): A research approach that scans the genomes of large populations to identify SNPs statistically associated with a trait or disease, typically testing hundreds of thousands to millions of variants simultaneously.

How Are SNPs Detected? SNP Analysis Methods

When you send a saliva sample to a genetic testing company, the laboratory extracts your DNA and reads it using one of several technologies. The most common method in direct-to-consumer testing is the SNP microarray, also called a genotyping chip.

SNP array (genotyping chip): A laboratory tool that simultaneously measures an individual's genotype at hundreds of thousands to roughly one million specific SNP positions across the genome, using hybridization of DNA to arrayed probes.

Modern SNP arrays genotype approximately one million variants in a single assay with greater than 99% accuracy. This is the technology behind services like 23andMe, AncestryDNA, and DeepDNA. The approach is cost-effective because it targets known, pre-selected SNP positions rather than reading the entire genome.

Whole genome sequencing (WGS), by contrast, reads every base pair of your DNA. It detects not only known SNPs but also rare and novel variants, structural changes, and insertions or deletions. WGS provides a more complete picture but at a higher cost, which is why most consumer genetic tests still rely on SNP arrays.

Your raw genetic data file from any of these services is essentially a long list of SNP positions and your genotype at each one — a personal catalog of your genetic variants.

SNPs in Personalized Medicine and Pharmacogenomics

One of the most immediate clinical applications of SNP analysis is pharmacogenomics: using genetic variants to predict how you will respond to medications.

The anticoagulant warfarin is a textbook example. Variants in the CYP2C9 gene affect how quickly the liver breaks down warfarin. Patients who carry slow-metabolizer SNPs need lower doses; prescribing a standard dose to these individuals increases the risk of dangerous bleeding. The FDA now includes pharmacogenomic information on the warfarin label, and many hospitals offer genotype-guided dosing.

The same principle applies across dozens of drugs. SNPs in CYP2D6 influence the metabolism of codeine, certain antidepressants, and tamoxifen. Variants in CYP2C19 affect how patients respond to the antiplatelet drug clopidogrel (Plavix) — a critical consideration after cardiac stent placement. The Clinical Pharmacogenetics Implementation Consortium (CPIC) has published guidelines for over 25 gene-drug pairs based on SNP evidence.

For a deeper look at how pharmacogenomics is being adopted in European healthcare systems, see our pharmacogenomics guide.

At DeepDNA, we see pharmacogenomics as one of the most actionable outputs of SNP analysis. Unlike disease risk — which involves complex gene-environment interactions — drug metabolism variants tend to have large, well-characterized effects that clinicians can act on immediately. This is where genomics stops being abstract and starts directly improving clinical outcomes.

From SNPs to Polygenic Risk Scores

Individual SNPs rarely tell the whole story for complex traits. This is why researchers developed polygenic risk scores (PRS): statistical models that aggregate the effects of hundreds of thousands of SNPs into a single number estimating genetic predisposition.

A PRS for coronary artery disease, for example, might weigh the contributions of over one million SNPs. Individuals in the top percentiles of such scores can have risk levels comparable to those with single-gene disorders like familial hypercholesterolemia — information that could prompt earlier screening and preventive intervention.

However, PRS have an important limitation: most of the GWAS data underlying current scores comes from populations of European ancestry. Scores developed in one population may perform poorly when applied to another, an equity gap the field is actively working to close. The All of Us Research Program and expanding biobank initiatives are generating more diverse datasets that will improve PRS accuracy across populations.

Frequently Asked Questions About SNPs

How many SNPs do humans have?
A typical person carries approximately 4 to 5 million SNPs compared to the human reference genome. The global catalog of known human SNPs in NCBI's dbSNP database contains 1.2 billion unique entries as of 2025, drawn from millions of sequenced individuals worldwide.

Are SNPs inherited?
Yes. SNPs are passed from parents to children following standard inheritance patterns. This is why they serve as powerful markers for ancestry analysis and family relationship testing — shared SNP patterns reveal shared lineage.

Can you change your SNPs?
No. SNPs are fixed, germline variations in your DNA sequence. Unlike epigenetic modifications (which can change over a lifetime in response to environment and behavior), the SNPs you were born with remain the same throughout your life.

What is the difference between a SNP and a mutation?
The distinction is largely one of frequency. Geneticists traditionally use "polymorphism" for variants found in at least 1% of a population and "mutation" for rarer changes. In practice, the field increasingly uses the neutral term "variant" for both, since the word "mutation" carries connotations of pathology that do not always apply.

Understanding Your Genetic Variants

SNPs are the most fundamental unit of human genetic diversity. Each one is a single-letter difference in the DNA code, but collectively they shape traits from hair texture to heart disease risk to how your body handles medication.

The practical value of understanding your SNPs has never been higher. Consumer genetic tests now analyze hundreds of thousands of these variants at a fraction of what it cost a decade ago, delivering actionable insights about ancestry, health predispositions, and drug response. As polygenic risk scores mature and pharmacogenomic guidelines expand, the relevance of SNP data to everyday healthcare decisions will only grow.

DeepDNA provides detailed SNP analysis covering health risk variants, pharmacogenomic markers, and ancestry informative markers — with results contextualized for European populations and GDPR-compliant data handling. If you are exploring alternatives to existing genetic testing services, our comparison guide breaks down what each platform offers.

---

Originally published at deepdna.ai